FdaApplication
ANDA 216582
Identifiers
- fda_app_no: ANDA216582
Properties
| Property | Value |
|---|---|
| applicant_name | PRINSTON PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2023-12-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PEMETREXED DISODIUM | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product